Video & Transcript : 'local pharmacies' :

Page 135 of 500
AZ
Transcript Highlights:
  • So they need to see that our local leaders are willing to be partners with them in advancing the treatments
  • know, once FDA approval is achieved, how the states can make sure that these drugs are put on the pharmacy
Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies held an informational hearing focused on psychedelic-assisted treatments for PTSD, depression, addiction, and related conditions, especially for veterans, first responders, and firefighters. The chair framed the issue as a response to long-standing barriers created by Schedule I restrictions and stigma, emphasizing that the committee was looking at supervised clinical use rather than take-home drugs. Members discussed the growing number of state psychedelic policy proposals, the federal breakthrough therapy pathway, and the idea of Arizona preparing for FDA approval and possibly sending correspondence to federal officials in support of expanded access and Right to Try implementation. Witnesses included retired Army Special Forces Master Sgt. Alan Mullen, who described participating in an ibogaine study for PTSD/TBI and said the treatment, combined with preparation and integration support, helped him confront trauma and showed promise under strict medical monitoring. Dr. Sue Sisley of Scottsdale Research Institute testified that her team is conducting FDA-controlled psychedelic trials, including psilocybin research funded by Arizona, and argued that these therapies can produce major symptom relief with limited doses when delivered in controlled settings. She also urged the legislature to help remove barriers to research and access, including support for Right to Try and possible federal action to allow controlled-substance access. Dan Freiberg of the Professional Fire Fighters of Arizona said firefighters face chronic mental health exposure and often lack effective options beyond traditional therapy or, in some cases, ketamine, and he supported any safe, effective treatment that could help members return to work and reduce suicide risk. Dr. Chung Trin, a mental health physician and trial investigator, explained the FDA breakthrough designation process, said several psychedelic treatments are in late-stage review, and stressed the need for Arizona to build clinical infrastructure so patients can access approved therapies quickly and safely once federal approval occurs. Committee members asked about safety, addiction potential, suicide risk, costs, patents, and whether natural versus synthetic versions of compounds like psilocybin would be available; the hearing ended with general support for continued research, possible legislative correspondence to federal officials, and no formal vote or bill action taken.
WA
Transcript Highlights:
  • program that we reviewed in 2016 and 2022, and the other is a data collection assignment related to local
  • they're intended to go to, and the state auditor's office has done a very good job of reviewing this To local
  • we think will ease the reporting requirement based on the ability to provide guidance to cities and local
  • So, to get a better understanding of whether there are things happening within the state or in local
  • There are over 600 kiosks across Washington located at pharmacies and other approved locations.
Summary: The Joint Legislative Audit and Review Committee met on January 7, 2026, approved the December minutes, and adopted an amended work plan. Staff proposed moving the drug takeback program sunset review up to 2026 and delaying the thermal energy network pilot review to 2028, which would free capacity for new studies. Members also noted bills that would eliminate two recurring JLARC reports, including one on unemployment insurance training benefits and one on lodging tax revenue reporting. The committee then discussed JLARC’s own performance measures and a pilot approach for evaluating tax preference performance statements in fiscal notes. Staff said JLARC will begin surveying members and the full legislature on satisfaction, track invitations to present to other committees, monitor recommendation resolution rates, staff retention, on-time report delivery, peer review results, and national recognition. For tax preference reviews, staff proposed a standard rubric to assess whether performance metrics match policy goals, are measurable, use reliable data, and allow enough time for evaluation; members generally supported the effort. Staff also outlined planned changes to public records reporting, including allowing agencies to opt out of tracking low-volume metrics, targeted outreach to nonreporting agencies, better data validation, clearer online guidance, and a survey of public records officers. The main audit presentation was a preliminary report on ignition interlock device compliance and monitoring. JLARC found that about 41% of drivers required to install devices had done so, with installation rates rising sharply with income; half of affected drivers earned less than $28,000 a year, and the typical annual device cost was about $2,700. Staff said the state’s financial assistance program has limited reach and lacks clear goals, performance measures, and coordination between the Department of Licensing and State Patrol. They recommended that the agencies formalize their roles and develop a coordinated strategy to improve installation rates. State Patrol and Licensing said they support the findings, described recent outreach pilots, and said they would work on a management plan and possible expansion of outreach efforts. JLARC also presented an expedited preliminary report on the drug take-back program’s fee setting and expenditures. Staff concluded that the current fee design limits the Department of Health’s ability to recover oversight costs and that public reporting of oversight expenditures would improve transparency. They recommended that DOH publicly report its oversight activities and that the legislature amend the fee structure to remove the cap tied to program operator expenditures. DOH agreed the current structure does not fully recover costs and said it would support a statutory change. The committee adjourned after noting its next regular meeting is scheduled for April 8, 2026.
WA

Washington 2025-2026 Regular Session

Senate Health & Long-Term Care Jan 27th, 2026 at 10:30 am

Health & Long-Term Care

Transcript Highlights:
  • The program does not preclude local governments from decriminalizing psychedelic substances or from deprioritizing
  • Additionally, the bill limits access by not fully respecting local decision-making.
  • It does not extend statutory protections to locally adopted resolutions that decriminalize or deprioritize
  • Department of Health, including drug cost payment amounts received for 340B drugs, payments made to pharmacies
FL

Florida 2026 Regular Session

Appropriations Committee on Health and Human Services Jan 14th, 2026

Appropriations Committee on Health and Human Services

Transcript Highlights:
  • adjust operating costs, increases in contracted professional medical services, and food product and pharmacy
  • We've had conversations with our local stakeholders.
  • We've had conversations with our local stakeholders. and the conversations with our local stakeholders
Summary: The Appropriations Committee on Health and Human Services heard presentations on the governor’s proposed fiscal year 2026-2027 budget for the health and human services agencies. Kendall Kelly outlined the overall HHS budget at $48.5 billion, with AHCA accounting for the largest share, and agency heads then highlighted major proposals for Medicaid behavioral health redesign, APD waiver enrollment and facility needs, DCF child welfare, opioid, and mental health investments, DOEA funding for Alzheimer’s, home care, and community services, DOH funding for cancer research, public health initiatives, and lab capacity, and VA funding for facility improvements, cybersecurity, and medication management. Several members praised specific proposals, including increased reimbursement for private duty nursing, Alzheimer’s supports, and the Florida FIRST blood-in-ambulance initiative. Senators also questioned the proposed changes to the AIDS Drug Assistance Program (ADAP), with the Surgeon General explaining that the department expects a reduction in covered patients from about 30,000 to about 20,000 because of funding pressures tied to rebates, federal changes, and premium tax credit issues. Public testimony strongly criticized the ADAP changes, citing lack of transparency and warning that many patients could lose access to medications. Other questions focused on the Office of Minority Health and Health Equity, DCF’s substance abuse and mental health data dashboard, Kids Care/CHIP expansion implementation, APD bed and facility planning, and the FX Medicaid technology project. DCF said about $7 million is set aside for the dashboard system, and AHCA said the governor’s budget includes $124.4 million for FX maintenance and continued module development, with $13.5 million to begin claims processing work. The committee did not take a substantive vote on the budget presentations and adjourned after questions and public testimony.
FL

Florida 2026 Regular Session

Appropriations Committee on Health and Human Services Jan 14th, 2026

Appropriations Committee on Health and Human Services

Transcript Highlights:
  • adjust operating costs, increases in contracted professional medical services, food product, and pharmacy
  • We've had conversations with our local stakeholders.
  • We've had conversations with our local stakeholders.
  • currently with the resources we have from the Ryan White program and the... conversations with our local
Summary: The Appropriations Committee on Health and Human Services heard presentations on the governor’s proposed FY 26-27 budget for the health and human services silo, which totals $48.5 billion within a $117.4 billion state budget. Agency leaders outlined major spending priorities, including AHCA’s behavioral health redesign, APD waiver enrollment and facility needs, DCF’s integrity and self-sufficiency systems, opioid response, community-based care and mental health bed expansion, DOEA’s Alzheimer’s, home care, and community care programs, DOH’s cancer research, public health, EMS blood-transfusion initiative, and lab feasibility study, and the Department of Veterans’ Affairs’ facility, cybersecurity, and medication-management investments. Members generally praised several proposals, especially increased reimbursement for private duty nursing, behavioral health funding, Alzheimer’s support, and the EMS blood program. Senator Sharief raised concerns about the AIDS Drug Assistance Program (ADAP), warning that changes could leave many Floridians without coverage for HIV medications and asking whether manufacturers could provide rebates directly to patients. Surgeon General Ladapo said the issue was driven largely by funding and federal changes, not a legal barrier, and said the department had explored alternatives but could not fill the gap with current resources. Senator Rouson asked about the Office of Minority Health and Health Equity, and DCF said its budget includes about $7 million for the substance abuse and mental health data dashboard required by prior legislation. Public testimony focused heavily on ADAP. Former program leaders and advocates said the proposed changes would reduce enrollment and remove key drugs and insurance-premium support, calling the situation a crisis and criticizing the department for lack of transparency and stakeholder engagement. They urged a pause and collaborative review of the program’s finances. The committee also discussed KidsCare implementation, with AHCA saying federal conditions and litigation have delayed the expansion. The meeting ended after the chair noted the budget would still need to be adjusted for updated Medicaid caseload estimates, and the committee adjourned without taking any formal votes or other action on the budget items.
FL

Florida 2025 Regular Session

November 18, 2025 - 03:30 PM

Transcript Highlights:
  • We recently opened a pharmacy in Miami and we also serve as ACC lead agency through the Triple A's and
  • So the models trend since local decision making to ensure statewide consistency and accountability.
  • The network is staffed by local councilors who understand the behavioral health providers and resources
  • entities in turn, also leverage some of their resources to do wellness promotion activities either in the local
NH

New Hampshire 2025 Regular Session

House Finance Division III (02/18/2025)

Transcript Highlights:
  • </c><00:16:59.480><c> communities</c><00:17:00.040><c> are</c> problem now in in local communities are
  • are our local schools being flooded is are our local schools being flooded by<00:17:05.839><c> immigrants
  • </c><01:59:28.480><c> school</c> are delivered the um the local school are delivered the um the local
  • The changing of the pharmacy ordering was that one of the five?
  • </c><02:12:50.639><c> ordering</c> the changing of the uh Pharmacy ordering the changing of the uh Pharmacy
Summary: The meeting began as a Division 3 work session on HB 71, but much of the early discussion focused on whether a previously discussed non-germane amendment could be considered or voted on that day. Members and the chair debated process and notice requirements, and the clerk’s guidance was that the amendment needed a separate public hearing before the full Finance Committee. The amendment was described as requiring DHHS contracts and addenda to include compliance with the Patient Bill of Rights, with a repeal date so the requirement would expire on November 30, 2026. The motion to move OTP on HB 71 with the amendment was withdrawn, and the committee agreed the amendment would be scheduled for a future full Finance hearing instead. The committee then turned to HB 71 itself and heard testimony from DHHS representatives John Williams and Jenny O’Higgins on the fiscal note and policy implications. Members questioned the estimate that the bill could put $12 million to $18 million per year in federal funding at risk, including HUD and Office of Refugee Resettlement funds. DHHS explained that the estimate was based on a broad reading of the bill’s term “specified alien,” which they said was not clearly defined in the bill, so they analyzed it using the federal definition of “alien” and assumed the bill could affect lawfully present non-citizens as well as undocumented individuals. They said the figure represented a worst-case scenario and that they were not claiming the loss was certain. Members also pressed DHHS on whether the bill could affect emergency sheltering in schools, public academies, or institutions of higher learning during disasters. DHHS said the language could create conflicts with federal funding conditions because emergency shelter programs generally cannot impose barriers on who may be sheltered, and they warned that excluding certain people could affect refugee-related and HUD funding. Questions were raised about whether the bill’s language would apply to private institutions as well as public ones, and whether the state could still use schools in short-term emergencies. DHHS said the language was broad, that they could not answer every legal question definitively, and that they would need input from public health and legal staff. No final vote on HB 71 was taken in the portion provided; the committee remained in discussion/work session mode after the amendment motion was withdrawn.
NM
Transcript Highlights:
  • On page 13, line 11, it says, after a health insurer or pharmacy benefits manager approves prior authorization
  • , every three months, they still have to go see their doctor to get the prescription sent to the pharmacy
Summary: The committee first heard Senate Bill 21, as amended, which would create an annual birthday-based open enrollment period for Medicare supplement policyholders age 65 and older, allowing them to switch to equal or lesser coverage without medical underwriting. The Aging and Long-Term Services Department and the Office of Superintendent of Insurance supported the bill as a consumer protection measure for seniors who are locked into rising premiums, while AHIP opposed it, warning it could raise premiums for existing policyholders. The League of Women Voters and AARP supported the measure. After debate over premium impacts and market stability, the committee voted 6-4 to give SB 21 a due pass. The committee then considered Senate Bill 20, dealing with prior authorization for medications used to treat serious mental illness. An amendment to change the bill from limiting prior authorization to once every three years to once every 12 months was debated; insurers supported the annual review, while nursing, disability, and mental health advocates argued that more frequent prior authorization would add burden and delay care. The committee tabled the amendment 5-4, then passed the unamended bill on a do pass vote. Testimony emphasized that the bill would not change how often patients see their doctors, only how often insurers can require prior authorization. Next, Senate Bill 101 was heard, which repeals the delayed sunset of the Health Care Delivery and Access Act so the hospital provider tax can continue. Sponsors and the Health Care Authority said the program has generated substantial federal matching funds and supports hospitals, especially rural facilities. AARP, Health Action New Mexico, the Greater Albuquerque Chamber of Commerce, and the New Mexico Hospital Association supported the bill. Committee members asked about how funds are distributed and reported; the agency said distributions are based on Medicaid discharges and hospitals must report on spending. The bill received a do pass. The committee also approved House Memorial 52, which requests a study group on health insurance premium affordability for working families and small employers. Supporters from Blue Cross and Blue Shield and AHIP said the memorial would help identify cost drivers and improve transparency. The committee then passed House Bill 132, as amended, creating a workers’ compensation presumption for certain occupational conditions affecting police officers. Supporters from labor, state police, OSI, and business groups said it would help recruitment, retention, and recovery, while members discussed the removal of back pain from the presumption and the reinstatement of PTSD. Finally, the committee began hearing Senate Bill 14, which expands the state’s health professional loan repayment program and creates a broader advisory structure to address workforce shortages. The bill would cover physicians and many other health professions, with a large appropriation and special provisions for part-time service and loan repayment terms. The sponsor described it as a competitive recruitment tool, and numerous health care, labor, and consumer groups testified in support. The sponsor also described a proposed amendment to reallocate physician funds to other eligible health professionals if there are not enough qualified physician applicants, but the committee was preparing to move on when the transcript ended.
NM

New Mexico 2026 Regular Session

House - Judiciary Feb 13th, 2026 at 05:37 pm

House Judiciary

Transcript Highlights:
  • just on the packaging, Madam Chair, representative of medication abortion that you receive in the pharmacy
  • So we're not hiding it at the pharmacy; it's just on the actual pill bottle.
Bills: HB195 , HB279 , SB30 , HB234 , HB292 , SB100 , SB23 , SB221 , SB261 , SB264
WA

Washington 2025-2026 Regular Session

Senate Human Services Jan 13th, 2026 at 01:30 pm

Human Services

Transcript Highlights:
  • We’ve been coordinating with the five managed care organizations and three pharmacy benefit managers
  • He constantly has to remind the pharmacy to order his monthly injections.
Bills: SB5873 , SB5895 , SB5945
WA

Washington 2025-2026 Regular Session

Senate Human Services Jan 13th, 2026

Transcript Highlights:
  • And we've been coordinating with the five managed care organizations and three pharmacy benefit managers
  • He constantly has to remind the pharmacy to order his monthly injections.
Summary: The committee began with a Department of Corrections update focused on agency culture, staff safety, reentry, and health services. Secretary Tim Lang highlighted DOC’s “Washington Way” approach, expanded visitation reforms, safety summits, community-corrections sanction changes, education and transportation improvements, partial confinement expansion, and efforts to increase volunteer and peer-led programming. Assistant Secretaries Danielle Armbruster and David Flynn described progress on Pell Grant implementation, reentry transportation, partial confinement, behavioral health standards, HIPAA compliance, the 1115 Medicaid waiver, telehealth expansion, and budget requests for opioid use disorder treatment, close-custody capacity, and staffing relief. Members asked about veterans’ units, telehealth for substance use treatment, women’s placement on the east side, correctional industries, and firefighting training. The new Office of Correction Ombuds director, Jeremiah Bourgeois, then outlined the office’s mission and limited resources, saying he would focus on the most serious complaints and continue building accountability with DOC. He described recent OCO reports, including findings of excessive force at the women’s prison, and said DOC had agreed to implement all recommendations. He also noted a new process for referring possible criminal misconduct to DOC leadership and law enforcement. Committee members praised the DOC-OCO partnership and Bourgeois’s appointment. The committee then heard Senate Bill 5895, which would add a new basis for extraordinary medical placement when DOC cannot meet an incarcerated person’s basic medical care needs. Senator Saldana said the bill is intended to provide a compassionate, workable path for people with serious or end-of-life medical needs while maintaining public safety. Testifiers in support included family members, Disability Rights Washington, and the League of Women Voters, who said the current EMP process is too restrictive and rarely results in release. DOC testified that it supports the EMP framework but has concerns about the bill’s definition of “basic medical care.” A former DOC physician suggested extending the qualifying time period and adding “approximately” to the language. The committee also heard Senate Bill 5873, which would expand escorted leaves of absence to include reentry-focused outings and broaden the family definition for funeral or bedside visits. Senator Wilson said the bill is meant to support a “slow release” and better prepare people for community reentry. DOC supported the concept, and witnesses from public defense, DOC reentry, and Amend said escorted reentry outings are consistent with evidence-based and international correctional practices. Finally, the committee heard Senate Bill 5945, which would limit persistent offender sentencing to convictions occurring after age 18 and require resentencing for affected people. Supporters argued the bill aligns with youth brain-development research and would address racial disparities; opponents, including prosecutors, victim advocates, and sheriffs’ representatives, said it would reopen painful cases, undermine finality, and impose costs. The hearing on that bill was still underway when the transcript ended.
MA

Massachusetts 2025-2026 Regular Session

Public Health Effects of Xylazine Feb 9th, 2026

Transcript Highlights:
  • And we suggest that state and local law enforcement review information on manufacturing and distribution
  • And we suggest that the state and local public health officials work with professional veterinary organizations
  • And we suggest that the state and local public health officials work with professional veterinary organizations
  • I think it's very, very important to educate the health care providers in their each specialties—pharmacy
  • our recommendations are that educational materials should be developed and distributed by state and local
Summary: The special commission on xylazine met virtually, called to order by House Chair Mindy Domb, with a quorum present. The commission approved the minutes from its December 11 public meeting and then reviewed the first draft of its final report, which is due to the Legislature by March 30, 2026. Staff explained the report structure, including a commission overview, findings and recommendations from each working group, and appendices with meeting materials and public resources. Commissioners discussed the distinction between licit veterinary xylazine and illicit xylazine in the drug supply, noting that the illicit supply is generally not diverted from legal veterinary sources but obtained through online vendors, and they clarified that xylazine is already classified in Massachusetts as a Schedule 6 substance, so the policy question is whether additional scheduling or penalties are warranted. For the best practices and enforcement section, staff recommended stronger guidance on secure storage and recordkeeping for authorized users, better reporting of diversion, theft, and suspicious orders, and focused enforcement on illicit production and fentanyl trafficking rather than individual possession. Commissioners suggested adding coordination among public safety, law enforcement, and the Attorney General’s office, as well as a state-level approach to emerging drug threats. In the outreach and treatment section, the draft emphasized that existing harm reduction, wound care, naloxone, and mobile outreach programs are effective but need broader coordination, more trauma-informed care, and better education for providers and first responders. Commissioners raised concerns about provider familiarity with xylazine, the need for first responders to include fire personnel and EMS, and the importance of not turning away people with xylazine-related wounds from recovery or treatment settings. The education and training section identified four target audiences: first responders, clinicians, non-clinicians in treatment and outreach settings, and people who use drugs and their families. The draft recommended tailored, stigma-free training and educational materials for each group, with consistent updates, continuing education credits where appropriate, and better access to centralized, real-time data on xylazine and other emerging contaminants. Commissioners discussed the need for centralized reporting and public health surveillance, including existing tools like the BSAS dashboard and StreetCheck, and several members urged the commission to recommend a DPH task force or similar body to monitor future drug supply threats. The meeting ended with staff outlining next steps: a revised draft would be circulated by the end of the week, feedback would be incorporated into a second draft by March 2, and the commission planned to vote on the final report at its March 9 meeting, with a backup meeting later in March if needed.
MA

Massachusetts 2025-2026 Regular Session

Public Health Effects of Xylazine Feb 9th, 2026

Transcript Highlights:
  • And we suggest that state and local law enforcement review information on manufacturing and distribution
  • And we suggest that the state and local public health officials work with professional vet organizations
  • And we suggest that the state and local public health officials work with professional vet organizations
  • It is very important to educate health care providers in their various specialties—pharmacy, especially
  • our recommendations are that educational materials should be developed and distributed by state and local
Summary: The Special Commission on xylazine convened a public meeting to review and discuss the first draft of its final report, approve prior minutes, and gather feedback for revisions. The commission first approved the December 11 minutes by roll call vote, then reviewed the report structure, which will include a commission overview, working group findings and recommendations, and appendices with public meeting materials and public resources. Staff explained the report’s framing of xylazine as both a licensed veterinary drug and an illicit drug supply contaminant, and members discussed the distinction between legal animal use and illicit importation/adulteration, with several commissioners emphasizing that people who use drugs do not intentionally seek xylazine. The commission then walked through draft findings and recommendations for best practices in oversight and enforcement, outreach and treatment, and education and training. Members discussed whether xylazine should be further scheduled or instead addressed through other public health and enforcement measures, with the draft leaning toward maintaining the current Schedule 6 status while strengthening public health responses, surveillance, drug checking, and targeted enforcement against illicit production and distribution. Commissioners also proposed stronger coordination among public safety, law enforcement, and public health, including real-time alerts, centralized data sharing, and possibly a DPH task force on emerging drug supply threats. The outreach and treatment section focused on existing harm reduction, wound care, naloxone, and mobile/low-threshold services, while noting gaps such as lack of an FDA-approved human reversal agent, geographic access barriers, insurance issues, and limited provider familiarity. A substantial portion of the meeting focused on education and training for first responders, clinicians, non-clinicians, and people who use drugs and their families. Commissioners supported tailored, stigma-free materials that cover xylazine basics, signs and symptoms, wound care, withdrawal, harm reduction, and when to seek medical care, with repeated emphasis on including firefighters, EMS, law enforcement, and other first responders in definitions and training. Members also stressed the need for consistent, centralized, and up-to-date public health data, better communication of emerging contaminants beyond xylazine, and practical guidance to prevent people with xylazine-related wounds from being turned away from care or recovery settings. The meeting ended with agreement to incorporate the feedback into a revised draft to be circulated by March 2, with another meeting scheduled for March 9 and a backup meeting later in March if needed; the commission then adjourned by unanimous motion.
NM

New Mexico 2026 Regular Session

Senate Chamber Jan 23rd, 2026 at 10:43 am

New Mexico Senate Floor Meeting

Transcript Highlights:
  • it's really specific about when you have authority as an entity to either hire a state employee, a local
  • it's really specific about when you have authority as an entity to either hire a state employee, a local
  • , this year in House Bill 2, you're going to see $155 million for maintenance and $100 million for local
  • Journalist Employment Income Tax Credit and Local Journalist Employment Corporate Income Tax Credit.
  • Senate Bill 120, creating the Local Journalist Employment Income Tax Credit and Local Journalist Employment
TX

Texas 89th Regular

Senate Session Apr 29th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • It's a local in my district.
  • Is this a not a local bill pretty much? It's a very big local bill. It's a local bill.
  • H.J.R. 8 to Business and Commerce, H.J.R. 31. to local government, H.J.R. 72 to local government, H.J.R
  • . 99 to local government.
  • . to local government, HB 363 to local government, HB 368 to criminal justice.
Bills: SJR59 , SCR30 , SCR46 , SB31 , SB127 , SB324 , SB401 , SB407 , SB467 , SB482 , SB506 , SB529 , SB584 , SB619 , SB636 , SB646 , SB647 , SB659 , SB715 , SB732 , SB735 , SB771 , SB784 , SB800 , SB801 , SB816 , SB1013 , SB1026 , SB1049 , SB1055 , SB1065 , SB1137 , SB1169 , SB1181 , SB1383 , SB1395 , SB1410 , SB1433 , SB1524 , SB1531 , SB1568 , SB1640 , SB1666 , SB1681 , SB1718 , SB1754 , SB1757 , SB1972 , SB1980 , SB2004 , SB2007 , SB2041 , SB2046 , SB2050 , SB2075 , SB2076 , SB2154 , SB2173 , SB2206 , SB2225 , SB2253 , SB2268 , SB2306 , SB2308 , SB2314 , SB2322 , SB2330 , SB2351 , SB2366 , SB2371 , SB2392 , SB2398 , SB2476 , SB2533 , SB2540 , SB2544 , SB2589 , SB2610 , SB2623 , SB2660 , SB2662 , SB2693 , SB2707 , SB2717 , SB2722 , SB2742 , SB2753 , SB2779 , SB2807 , SB2843 , SB2844 , SB2858 , SB2877 , SB2880 , SB2885 , SB2920 , SB2938 , SB2986 , HJR4 , HCR35 , SJR3 , SJR18 , SB5 , SB260 , SB1786 , SB914 , SB963 , SB1197 , SB1415 , SB1437 , SJR36 , SJR50 , SJR63 , SJR84 , SJR59 , SCR12 , SCR39 , SCR46 , SCR48 , SCR19 , SCR30 , SCR3 , SB2023 , SB1433 , SB2322 , SB2877 , SB407 , SB1718 , SB1395 , SB62 , SB666 , SB847 , SB284 , SB854 , SB1073 , SB810 , SB1505 , SB583 , SB1502 , SB507 , SB1026 , SB1434 , SB1376 , SB1585 , SB1772 , SB2016 , SB1163 , SB619 , SB1122 , SB732 , SB731 , SB397 , SB508 , SB1436 , SB287 , SB261 , SB1882 , SB393 , SB1791 , SB529 , SB209 , SB2429 , SB1999 , SB511 , SB2309 , SB510 , SB2253 , SB584 , SB1085 , SB2314 , SB2046 , SB1975 , SB2717 , SB1262 , SB1524 , SB1137 , SB636 , SB2056 , SB884 , SB517 , SB1200 , SB1410 , SB1845 , SB1863 , SB2681 , SB2200 , SB2199 , SB1757 , SB2050 , SB2458 , SB2201 , SB1055 , SB2660 , SB2662 , SB1065 , SB801 , SB2533 , SB3014 , SB3013 , SB758 , SB647 , SB1721 , SB2268 , SB2366 , SB1013 , SB2797 , SB2371 , SB2383 , SB646 , SB1169 , SB1754 , SB2779 , SB2004 , SB2119 , SB2448 , SB1777 , SB1283 , SB2392 , SB2076 , SB2786 , SB2876 , SB2284 , SB2225 , SB1540 , SB2920 , SB2929 , SB1972 , SB2540 , SB2742 , SB2595 , SB2217 , SB715 , SB2330 , SB1383 , SB500 , SB1640 , SB2001 , SB2080 , SB2722 , SB506 , SB2514 , SB2623 , SB2753 , SB2398 , SB1241 , SB2927 , SB2173 , SB2538 , SB898 , SB467 , SB1449 , SB2529 , SB1531 , SB2846 , SB2476 , SB986 , SB1181 , SB2075 , SB2154 , SB2864 , SB31 , SB2880 , SB1359 , SB2386 , SB771 , SB2844 , SB2550 , SB1351 , SB1423 , SB1931 , SB2245 , SB2589 , SB2707 , SB2807 , SB2351 , SB410 , SB659 , SB816 , SB2776 , SB2693 , SB2580 , SB1980 , SB1886 , SB1234 , SB739 , SB482 , SB456 , SB127 , SB1666 , SB2843 , SB2801 , SB800 , SB2055 , SB784 , SB2986 , SB735 , SB1012 , SB324 , SB2926 , SB2938 , SB2007 , SB2138 , SB1242 , SB2615 , SB1049 , SB2310 , SB1224 , SB2972 , SB1568 , SB2841 , SB2885 , SB3016 , SB2858 , SB2610 , SB2139 , SB1856 , SB2035 , SB2308 , SB2306 , SB2041 , SB1528 , SB1681 , SB1141 , SB2401 , SB2530 , SB2375 , SB547 , SB1266 , SB1373 , SB1467 , SB2069 , SB2269 , SB2480 , SB2544 , SB672 , SB904 , SB2695 , SB2891 , SB2422 , SB2543 , SB1854 , SB317 , SB2539 , SB2532 , SB2925 , SB1250 , SB2082 , SB2203 , SB457 , SB2357 , HJR4 , HB135 , HB 1109 , HCR35 , HCR64 , SB2721 , SB243 , SB1285 , SB2568 , SB1959 , SB1442 , SB1454 , SB2520 , SB2541 , SB1708 , SB1237 , SB1844 , SB1586
NM

New Mexico 2026 Regular Session

House - Chamber Meeting Part 2 Feb 12th, 2026 at 12:58 pm

New Mexico House Floor Meeting

Transcript Highlights:
  • even now with our New Mexico Grown Program, districts like Las Lunas and Velarde and Berlin are using local
  • four in cheese, and I believe that it is still the case that every one of New Mexico dairies are locally
  • time when we see so much political division around this country that sometimes percolates down to our local
  • $13.25 million for the PPRF in three identified funds: the drinking water state revolving fund, a local
  • Not the people that have a chance to go to their local bank and qualify for these homes.
Bills: HB111 , HB108 , HB145 , HB164 , HB291 , HJR6 , HR1 , HB63 , HB64 , HB165 , HB184 , HB200 , HB4 , HB7 , HB20 , HB65 , HB66 , HB80 , HB88 , HB96 , HB166 , HB285 , HB295 , HB306 , SB29 , SB37 , HJM2 , HJM3 , HJM1 , HM7 , HM17 , HM4 , HM22 , HM23 , HM24 , HM26 , HM2 , HM16 , HM32 , HM13 , HM47 , HM20 , HM51 , HM1 , HM31 , HM35 , HM36 , HM46 , HM53 , HM54 , HM11 , HM14 , HM21 , HM34 , HM50
TX

Texas 89th Regular

S/C on Defense & Veterans' Affairs Mar 3rd, 2025

S/C on Defense & Veterans' Affairs

Transcript Highlights:
  • We serve... both local authorities and also we augment our brothers in arms, which is National Guard
  • They help with enrollment, eligibility, billing issues, doctor appointments, prescriptions. pharmacy
  • There are 60 peer service coordinators located in local mental health authorities, and what they do,
  • And it could be VA services, it could be private, it could be the local mental health authority.
  • We have four service officers that work in conjunction with a Texas veteran. and their local offices
CA
Transcript Highlights:
  • I'm part of AFSCME Local 2620.
  • I'm part of the Ask Me Local 2620.
  • I'm a proud member of AFSCME Local 2620.
  • I'm with AFSCME Local 2620.
  • I'm with AFSCME Local 2620.
Summary: The Assembly Budget Subcommittee on Human Services heard testimony on Department of Developmental Services (DDS) and related budget and trailer bill proposals, with a major focus on the impacts of H.R. 1 on people with intellectual and developmental disabilities (IDD). DDS and the Department of Social Services (DSS) said H.R. 1 could affect Medi-Cal and CalFresh access, but that people with disabilities and caregivers are exempt from the work requirements; the administration is working on data matching and automation through the statewide eligibility system to identify exemptions, with June 1, 2026 as the implementation date for CalFresh changes. Witnesses and advocates warned that any loss of Medi-Cal could create fiscal pressure on regional centers and households, while public commenters described the real-life consequences of losing services. Committee members repeatedly expressed concern about cost shifts to counties and asked for harm-mitigation strategies before the May Revision. The committee also reviewed the governor’s IHSS-related proposals. DSS said the budget would set a baseline for authorized hours, align IHSS disenrollment/reinstatement with Medi-Cal eligibility processes, and eliminate the IHSS backup provider system, while emphasizing that individual service hours would still be based on assessed need. DDS said if a person loses IHSS or Medi-Cal, regional centers may have to step in as payer of last resort for some services, potentially at higher state cost. Members and the Legislative Analyst’s Office questioned whether counties could absorb the proposed shifts without reducing services, and asked for more detail on implementation, data quality controls, and how regional centers could help families navigate disruptions. A separate trailer bill on DDS rate reform and the Quality Incentive Program drew mixed reactions. DDS proposed extending a contract exemption and delaying final rate reform regulations to 2030, saying the changes are budget-neutral and needed for implementation. DDS reported that about 81% of providers had completed the current Quality Incentive Program requirements, but providers and advocates argued the 90-10 structure can function like a penalty and may destabilize services if providers lose 10% of funding. Committee members asked for clearer assistance to providers, possible flexibility for good-faith efforts, and a redlined version of the language before the May Revision. The committee also heard DDS’s proposed trailer bill on regional center governance and provider capacity. DDS said the language would consolidate regional center contracts and performance measures, strengthen board training and oversight, require consumer advisory committees, expand independent legal support, raise the threshold for board approval of contracts, and remove barriers such as physical-office requirements and duplicate vendorization. DDS said the goal is to improve accountability and efficiency while preserving person-centered services, and members indicated they wanted further refinement and stakeholder input before moving forward.
MN

Minnesota 2025-2026 Regular Session

Committee on Human Services - 01/27/25

Human Services

Transcript Highlights:
  • </c><00:05:20.840><c> services</c><00:05:21.720><c> and</c><00:05:21.880><c> our</c> operations Pharmacy
  • services and our operations Pharmacy services and our quality<00:05:22.479><c> and</c> Compliance.
  • :48.079><c> this</c> solution so that we can alleviate this solution so that we can alleviate this local
  • County and Hospital uh bottleneck local County and Hospital uh bottleneck and<00:14:52.959><c> I</c>
  • </c><00:40:27.319><c> local</c> who serve on the state local local who serve on the state local local